Eric Green | executive |
Bernard Birkett | executive |
Paul Knight | analyst |
Lawrence Solow | analyst |
Justin Bowers | analyst |
Matthew Larew | analyst |
Jacob Johnson | analyst |
Daniel Leonard | analyst |
David Windley | analyst |
Good morning, and welcome to West's Second Quarter 2024 Conference Call.
Our way of introduction, this is John Sweeney, the new Head of Investor Relations at West. I'm delighted to be here, and I look forward to working with all of you.
We issued our financial results earlier this morning, and the release has been posted in the Investors section on the company's website located at westpharma.com.
On the call today, we'll review our financial results provide an update on our business and present an updated financial outlook for the full year 2024.